LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 7 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $57,401,000 | +28.0% | 16,298,000 | 0.0% | 0.67% | +15.0% |
| Q2 2018 | $44,858,000 | -11.0% | 16,298,000 | -29.2% | 0.58% | -10.9% |
| Q1 2018 | $50,410,000 | +203.6% | 23,025,000 | +153.7% | 0.65% | +288.1% |
| Q4 2017 | $16,604,000 | -30.1% | 9,075,000 | -44.7% | 0.17% | -45.3% |
| Q4 2016 | $23,743,000 | -12.0% | 16,416,000 | -10.9% | 0.31% | -23.8% |
| Q3 2016 | $26,970,000 | -34.0% | 18,416,000 | -24.7% | 0.40% | -35.0% |
| Q2 2016 | $40,849,000 | +9.5% | 24,445,000 | 0.0% | 0.62% | -41.5% |
| Q1 2016 | $37,293,000 | -1.4% | 24,445,000 | 0.0% | 1.06% | +30.2% |
| Q4 2015 | $37,808,000 | +19.4% | 24,445,000 | 0.0% | 0.81% | +9.0% |
| Q3 2015 | $31,664,000 | – | 24,445,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |